Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Real Estate
  • Entertainment
  • Business
  • Technology
  • Health
  • Artificial Intelligence
ncarol.com

Utah attempts to legalize placenta cell therapy
ncarol.com/10257689

Trending...
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST)
  • Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - ncarol.com -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on ncarol.com
  • What's Beneath Your Feet?: Anti-Viral Flooring Helps Create Healthier Spaces
  • Control & Co. Launches Digital Audit Readiness Toolkit for Small Businesses
  • Zazie Productions Brings Experimental Sound Art to Psychological Horror Film Scoring
  • Tek84 Unveils New Brand Identity Built to Magnify What Security Officers Can Do
  • CoreVar Announces Cooking with AI, an Eight-Topic Live Webinar Series

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST)
  • Wave Helicopters Takes FLIBS 2026 to New Heights
  • Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature
  • VINCE Lifestyle Magazine Launches Membership Drive to Support and Empower Adults 40+
  • Latin GRAMMY-Winning Cuban-American Conductor Dr Yalil Guerra to Lead Pepperdine's Oklahoma!
  • Highsfield Showcases Earth Zoom Generator for Cinematic AI Videos
  • Patton AI Launches Patton Hive 4.5: Wartime Breakthroughs for Drones and Robots When GPS Goes Dark
  • Wisdom trumps wrinkles: 66% of Aussie women wouldn't turn back the clock
  • Attorney Jason M. Sullivan Quoted in The Telegraph on Trump's $10 Billion BBC Lawsuit
  • Sycamore Dove Releases "Loving Every Moment"
  • Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Nashville
  • Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
  • Beyond Popularity Rankings, The World's No.1 Superstar® Wins Best Pop Music Video for "Under Your Spell"
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms
  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection
  • National Literacy and Workforce Readiness Crisis Sparks New Program Launching in Birmingham
  • New England Consulting Partners Celebrates 25 Years of Turnaround Management Solutions
  • RAS AP Consulting Releases Educational Resource to Help Organizations Prepare for IRS FIRE-to-IRIS Transition
  • Roots, Rhythm & Joy Invites Neighbors to Find Community Through Music
_catLbl0 _catLbl1

Popular on ncarol.com

  • Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era - 149
  • 2026 Triangle Parade of Homes Features Over 300 Homes - 126
  • Parade of Homes Winners Announced - 122
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover - 118
  • Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order - 115
  • Tulsa Air & Space Museum Launches "Give $16 for the F-16" Challenge to Bring Thunderbird Home for Veterans Day - 114
  • LowSignalMail Lets Users Handle Gmail by Text Message - 109
  • Crossroads4Hope Launches Blood Cancer Resource Hub - 105
  • Remodelers Outstanding Construction Awards Announced - 103
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME - 102

Similar on ncarol.com

  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
  • Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Thar Process Partners with French Leader ExtrateX to Bring Prep to Process-Scale SFC to Europe
  • Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute